This K01 career development award applicant is trained as a genetic epidemiologist and his research has genome wide association studies (GWAS) of gastrointestinal diseases such as colorectal adenoma and gallstone disease. He recently led a study that identified novel genetic markers of gallstone disease in a GWAS meta-analyses within 10 international cohorts. In this proposal, the candidate seeks to continue his work on gallbladder disease, and work on application of knowledge from `omic' studies, into the clinic for individualized patient care. He plans to develop metabolomics based biomarkers to predict the risk of symptomatic gallbladder disease. He will then determine their clinical effectiveness in predicting persistence of symptoms in cholecystectomy patients, and the cost-effectiveness of these biomarker tools using mathematical simulation models. The overarching hypothesis of this proposal is that metabolomic signatures can accurately distinguish patients with biliary-type pain that are more likely to benefit from cholecystectomy from those for whom cholecystectomy may be unnecessary. This proposal will allow him to expand his training from the population-based setting to patient oriented research, and gain experience in comparative effectiveness analyses. To complete this proposal, the candidate will require additional training in the areas of decision sciences, patient oriented research and metabolomics. He will benefit from a multidisciplinary mentoring committee, consisting of internationally recognized experts in gastroenterology, clinical epidemiology, health decision sciences, biomarker epidemiology, and metabolomics. His training plan, developed with close supervision of his mentoring committee, will include didactic coursework at HSPH with the objective to gain fluency with key concepts in these training areas. The candidate's primary mentor Dr. Andrew T. Chan has an established track record of effectively mentoring fellows and junior faculty towards successful academic careers. His research advisory committee will not only provide methodological expertise, but also mentoring support, guidance and critical focused so far on gene-environment interactions in the risk of cancers, and feedback to ensure the candidate's transition towards independence . The research environment, which includes MGH Clinical and Translational Epidemiology Unit, MGH Division of Gastroenterology, the Channing Division of Network Medicine, The Harvard Clinical and Translational Science Center and the Harvard T H Chan School of Public Health will provide vast collaborative resources, relevant advanced course-work, seminars and other didactic training opportunities for the candidate during this critical developmental period. Through this award, the candidate will realize his long term goal of becoming an independent translational investigator, and establishing a research program in a clinical setting, with specific focus on gastrointestinal diseases.

Public Health Relevance

Gallbladder disease is the leading cause for gastrointestinal-related hospital admissions in the United States, resulting in substantial morbidity and healthcare costs. The purpose of this study is to identify metabolomic signatures of symptomatic gallbladder disease, and to develop metabolomics based biomarker tools to predict the outcomes of cholecystectomy surgery. The proposed research has the potential to identify patients with biliary type abdominal pain who can be safely managed using conservative management, thereby reducing the number of unnecessary cholecystectomies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01DK110267-04
Application #
9750715
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Saslowsky, David E
Project Start
2016-09-01
Project End
2021-07-31
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Su, Yu-Ru; Di, Chongzhi; Bien, Stephanie et al. (2018) A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics. Am J Hum Genet 102:904-919
Nguyen, Long H; Lochhead, Paul; Joshi, Amit D et al. (2018) No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication. Gastroenterology 154:1290-1297.e1
Mehta, Raaj S; Abu-Ali, Galeb S; Drew, David A et al. (2018) Stability of the human faecal microbiome in a cohort of adult men. Nat Microbiol 3:347-355
Aschard, Hugues; Tobin, Martin D; Hancock, Dana B et al. (2017) Evidence for large-scale gene-by-smoking interaction effects on pulmonary function. Int J Epidemiol 46:894-904
Dimitrakopoulou, Vasiliki I; Tsilidis, Konstantinos K; Haycock, Philip C et al. (2017) Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study. BMJ 359:j4761
Lochhead, Paul; Hagan, Kaitlin; Joshi, Amit D et al. (2017) Association Between Proton Pump Inhibitor Use and Cognitive Function in Women. Gastroenterology 153:971-979.e4
Khalili, Hamed; de Silva, Punyanganie S; Ananthakrishnan, Ashwin N et al. (2017) Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis 23:1088-1095